Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

About

Andrew A. Wilson MD, is a board-certified pulmonologist at Boston Medical Center (BMC) and an expert in caring for patients with Alpha-1 antitrypsin deficiency (AATD), the most common heritable cause of emphysema. Dr. Wilson is also an associate professor of Pulmonary, Allergy, Sleep & Critical Care Medicine and a primary mentor of graduate students at Boston University Chobanian & Avedisian School of Medicine. His research focuses on advancing the understanding of and treatment for AATD and chronic obstructive pulmonary disease (COPD). Dr. Wilson is the director of the Alpha-1 Center as well as a member of Boston University’s Pulmonary Center, Center for Regenerative Medicine and Evans Center for Interdisciplinary Biomedical Research.
  • Departments

  • Specialties

    Alpha-1 antitrypsin deficiency (AATD), chronic obstructive pulmonary disease (COPD)

  • Administrative Title

    Associate Professor of Pulmonary, Allergy, Sleep & Critical Care Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, University of Texas Southwestern Medical Center, 1999-2002
  • Education

    University of Texas Southwestern Medical School, 1999
  • Board Certifications

    Pulmonary Disease and Critical Care Medicine, American Board of Internal Medicine

Affiliations

Affiliations